PROGLIOV

Serial Number 98282641
730

Registration Progress

Application Filed
Nov 22, 2023
Under Examination
Nov 19, 2024
Approved for Publication
Oct 8, 2024
Published for Opposition
Oct 8, 2024
Registered

Attorney Assistance

Statement of Use Due - Extension 1 Granted
Due: Nov 19, 2025 132 days

Trademark Image

PROGLIOV

Basic Information

Serial Number
98282641
Deadline
November 19, 2025
Description
Statement of Use or 2nd Extension Due
Filing Date
November 22, 2023
Published for Opposition
October 8, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
730
Status Date
Mar 7, 2025
Application
Pending
Classes
005

Rights Holder

BESINS HEALTHCARE LUXEMBOURG S.A.R.L.

99
Address
2-8, rue
Julien Vesque L-2668
LU

Ownership History

BESINS HEALTHCARE LUXEMBOURG S.A.R.L.

Original Applicant
99
Julien Vesque LU

BESINS HEALTHCARE LUXEMBOURG S.A.R.L.

Owner at Publication
99
Julien Vesque LU

Legal Representation

Attorney
Julianne Abelman

USPTO Deadlines

Next Deadline
132 days remaining
Statement of Use Due - Extension 1 Granted
Due Date
November 19, 2025
Extension Available
Until November 19, 2025

Application History

18 events
Date Code Type Description
Mar 8, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 8, 2025 EX1G S SOU EXTENSION 1 GRANTED
Mar 7, 2025 EXT1 S SOU EXTENSION 1 FILED
Mar 7, 2025 EEXT I SOU TEAS EXTENSION RECEIVED
Nov 19, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 8, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 8, 2024 PUBO A PUBLISHED FOR OPPOSITION
Sep 18, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 31, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 16, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 16, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 16, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 26, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 26, 2024 GNRT F NON-FINAL ACTION E-MAILED
Jun 26, 2024 CNRT R NON-FINAL ACTION WRITTEN
Jun 25, 2024 DOCK D ASSIGNED TO EXAMINER
Jan 16, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 25, 2023 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Pharmaceutical preparations for human use with progesterone as active ingredient for estrogen replacement therapy in the perimenopausal and postmenopausal period and for use for disorders due to progesterone insufficiency

Classification

International Classes
005